Daptomycin non-susceptible meticillin-resistant Staphylococcus aureus USA 300 isolate

Journal of Medical Microbiology

Volumn 57, Issue 8, 2008, Pages 1036-1038

  Murthy, Madhukiran H ^a   Olson, Michael E ^b   Wickert, Robert W ^b   Fey, Paul D ^b   Jalali, Ziba ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAPTOMYCIN; GENTAMICIN; RIFAMPICIN; VANCOMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIUM CULTURE; BACTERIUM ISOLATE; BLOOD CULTURE; CASE REPORT; DRUG WITHDRAWAL; GENE MUTATION; GRAM POSITIVE BACTERIUM; HUMAN; KIDNEY FUNCTION; LONG TERM CARE; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; THORAX SURGERY; TREATMENT DURATION; UNITED STATES;

ADULT; ANTI-BACTERIAL AGENTS; DAPTOMYCIN; HEPATITIS C; HUMANS; MALE; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 50249138332     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.2008/000588-0     Document Type: Article

References (17)

1. Alborn, W. E., Allen, N. E. & Preston, D. A. (1991). Daptomycin disrupts membrane potential in growing Staphylococcus aureus. Antimicrob Agents Chemother 35, 2282-2287.
2. Bannerman, T. L., Hancock, G. A., Tenover, F. C. & Miller, J. M. (1995). Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus. J Clin Microbiol 33, 551-555.
3. CLSI (2007). Performance Standards for Antimicrobial Susceptibility Testing. Approved Standards M100-S17. Wayne, PA: Clinical and Laboratory Standards Institute.
4. Cui, L., Tominaga, E., Neoh, H. & Hiramatsu, K. (2006). Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin intermediate Staphylococcus aureus. Antimicrob Agents Chemother 50, 1079-1082.
5. Diep, B. A., Gill, S. R., Chang, R. F., Phan, T. H., Chen, J. H., Davidson, M. G., Lin, F., Lin, J., Carleton, H. A. & other authors (2006). Complete genome sequence of USA300, an epidemic clone of community-acquired methicillin-resistant Staphylococcus aureus. Lancet 367, 731-739.
6. Eisenstein, B. I. (2004). Lipopeptides, focusing on daptomycin for the treatment of gram-positive infections. Expert Opin Investig Drugs 13, 1159-1169.
7. Fey, P. D., Said-Salim, B., Rupp, M. E., Hinrichs, S. H., Boxrud, D. J., Davis, C. C., Kreiswirth, B. N. & Schlievert, P. M. (2003). Comparative molecular analysis of community or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 47, 196-203.
8. Friedman, L., Alder, J. D. & Silverman, J. A. (2006). Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus. Antimicrob Agents Chemother 50, 2137-2145.
9. Jones, T., Yeaman, M. R., Sakoulas, G., Yang, S. J., Proctor, R. A., Sahl, H. G., Schrenzel, J., Xiong, Y. Q. & Bayer, A. S. (2008). Failures in clinical treatment of Staphylococcus aureus with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding. Antimicrob Agents Chemother 52, 269-278.
10. Kaatz, G. W., Lundstrom, T. S. & Seo, S. M. (2006). Mechanisms of daptomycin resistance in Staphylococcus aureus. Int J Antimicrob Agents 28, 280-287.
11. Mangili, A., Bica, I., Snydman, R. & Hamer, D. H. (2005). Daptomycin-resistant methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 40, 1058-1060.
12. Marty, F. M., Yeh, W. W., Wennersten, C. B., Venkataraman, L., Albano, E., Alyea, E. P., Gold, H. S., Baden, L. R. & Pillai, S. K. (2006). Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis. J Clin Microbiol 44, 595-597.
13. McDougal, L. K., Steward, C. D., Killgore, G. E., Chaitram, J. M., McAllister, S. K. & Tenover, F. C. (2003). Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 41, 5113-5120.
14. Naimi, T. S., LeDell, K. H., Como-Sabetti, K., Borchardt, S. M., Boxrud, D. J., Etienne, J., Johnson, S. K., Vandenesch, F., Fridkin, S. & other authors (2003). Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290, 2976-2984.
15. Sakoulas, G., Alder, J., Thauvin, C., Moellering, R. C. & Eliopolous, G. M. (2006). Induction of daptomycin heterogenous susceptibility in Staphylococcus aureus by exposure to vancomycin. Antimicrob Agents Chemother 50, 1581-1585.
16. Silverman, J. A., Perlmutter, N. G. & Shapiro, H. M. (2003). Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob Agents Chemother 47, 2538-2544.
17. Skiest, D. J. (2006). Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin. J Clin Microbiol 44, 655-656.